Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Surgery Partners, Inc. SGRY
$35.25
+$0.07 (0.20%)
На 18:00, 12 мая 2023
+81.56%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
4458420000.00000000
-
week52high
46.47
-
week52low
20.46
-
Revenue
2539300000
-
P/E TTM
97
-
Beta
2.74186800
-
EPS
-0.55000000
-
Last Dividend
0.00000000
-
Next Earnings Date
31 июл 2023 г. в 12:30
Описание компании
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| RBC Capital | Outperform | Outperform | 03 авг 2022 г. |
| B of A Securities | Neutral | Buy | 15 июн 2022 г. |
| Citigroup | Buy | Buy | 04 мая 2022 г. |
| SVB Leerink | Outperform | Outperform | 02 мар 2022 г. |
| JP Morgan | Neutral | Neutral | 02 мар 2022 г. |
| SVB Leerink | Outperform | Outperform | 10 ноя 2022 г. |
| RBC Capital | Outperform | Outperform | 10 ноя 2022 г. |
| Citigroup | Buy | Buy | 09 ноя 2022 г. |
| SVB Leerink | Outperform | Outperform | 22 ноя 2022 г. |
| Benchmark | Buy | Buy | 05 дек 2022 г. |
| RBC Capital | Outperform | Outperform | 23 ноя 2022 г. |
| Barclays | Overweight | Overweight | 18 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| HENDRIX BLAIR E | A | 58248249 | 9183673 | 23 ноя 2022 г. |
| BAIN CAPITAL INVESTORS LLC | A | 58248249 | 9183673 | 23 ноя 2022 г. |
| O'Reilly T. Devin | A | 58248249 | 9183673 | 23 ноя 2022 г. |
| DeLuca Teresa | A | 47968 | 20000 | 21 ноя 2022 г. |
| TURNER BRENT | A | 57701 | 10000 | 21 ноя 2022 г. |
| Brocklehurst Laura L. | D | 41424 | 4338 | 09 ноя 2022 г. |
| Doherty David T | D | 58579 | 171 | 30 авг 2022 г. |
| Brocklehurst Laura L. | D | 45762 | 162 | 30 авг 2022 г. |
| Brocklehurst Laura L. | D | 45924 | 196 | 29 июн 2022 г. |
| Goodwin George | D | 27806 | 4000 | 07 июн 2022 г. |
Новостная лента
Surgery Partners, Inc. (SGRY) Q1 2023 Earnings Call Transcript
Seeking Alpha
01 мая 2023 г. в 23:05
Surgery Partners, Inc. (NASDAQ:SGRY ) Q1 2023 Earnings Conference Call May 1, 2023 5:00 PM ET Company Participants Dave Doherty - Executive Vice President and Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Jason Cassorla - Citi Nabil Gutierrez - Bank of America Brian Tanquilut - Jefferies Lisa Gill - JPMorgan Whit Mayo - SVB Securities Bill Sutherland - The Benchmark Company Stephen Valiquette - Barclays Operator Greetings, and welcome to the Surgery Partners First Quarter 2023 Earnings Call. At this time all participants are in a listen-only mode.
Surgery Partners (SGRY) Q1 Earnings and Revenues Beat Estimates
Zacks Investment Research
01 мая 2023 г. в 19:01
Surgery Partners (SGRY) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.09 per share a year ago.
Surgery Partners, Inc. Announces First Quarter 2023 Earnings Release Date and Conference Call Details
GlobeNewsWire
19 апр 2023 г. в 06:00
BRENTWOOD, Tenn., April 19, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2023 results after market close on Monday, May 1, 2023, to be followed by a conference call at 5:00 p.m. (Eastern Time)
Surgery Partners: Loss Making Yet A Promising Opportunity In The Surgical Services
Seeking Alpha
19 февр 2023 г. в 23:39
Surgery Partners provides surgical services to patients across the US. The company's recent acquisition of National Surgical Healthcare presents an opportunity for further expansion and revenue growth.
Surgery Partners, Inc. Announces Fourth Quarter 2022 Earnings Release Date and Conference Call Details
GlobeNewsWire
09 февр 2023 г. в 16:15
BRENTWOOD, Tenn., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2022 results before the market opens on Wednesday, March 1, 2023, to be followed by a conference call at 8:30 a.m. (Eastern Time).